1. Home
  2. WATT vs LEXX Comparison

WATT vs LEXX Comparison

Compare WATT & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energous Corporation

WATT

Energous Corporation

HOLD

Current Price

$8.67

Market Cap

19.9M

Sector

Technology

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.71

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WATT
LEXX
Founded
2012
2004
Country
United States
Canada
Employees
26
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.9M
18.9M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
WATT
LEXX
Price
$8.67
$0.71
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
520.8K
204.6K
Earning Date
02-26-2026
01-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,018,000.00
$522,000.00
Revenue This Year
$509.64
$13.35
Revenue Next Year
$210.44
$78.83
P/E Ratio
N/A
N/A
Revenue Growth
600.23
5.05
52 Week Low
$3.62
$0.46
52 Week High
$18.36
$1.91

Technical Indicators

Market Signals
Indicator
WATT
LEXX
Relative Strength Index (RSI) 75.36 42.82
Support Level $6.75 $0.71
Resistance Level $9.62 $0.80
Average True Range (ATR) 0.76 0.07
MACD 0.32 0.00
Stochastic Oscillator 85.90 16.89

Price Performance

Historical Comparison
WATT
LEXX

About WATT Energous Corporation

Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: